Sysmex America announces CEO's retirement

LabPulse.com staff writers
Sep 12, 2021
2021 09 14 14 50 7252 Lb 2021 09 13 Sysmex Ceo Retires 400

Sysmex America announced that Ralph Taylor, the company's CEO, will retire as of September 30. Taylor will be succeeded by Andy Hay, currently chief operating officer of the company.

Taylor joined the company in 2007 as vice president of marketing. In 2018, he was tapped as the company's CEO.

Hay has served with Sysmex America for 32 years, for 21 of which he led Sysmex's sales, marketing, research and development, training, and operations efforts.

Andy Hay. Image courtesy of Sysmex.Andy Hay. Image courtesy of Sysmex.
Latest in Collaboration
Dna Genome Gene Targeted Social
Exact Sciences, Watchmaker Genomics partner to improve DNA methylation technology
September 6, 2023
Test Tube Liquid Sample Social
Twist Bioscience, Ono Pharmaceutical to collaborate on autoimmune disease drug development
September 5, 2023
At-home or Lab-based STI testing/collection
Sponsored
At-home or Lab-based STI testing/collection
September 6, 2023
Business Handshake Intelligence Social
Oxford Nanopore, IQVIA form nanopore sequencing partnership
August 31, 2023
Related Stories
2019 07 15 19 08 6013 Amyloid Plaque Alzheimer 400
Alzheimer's
Sysmex, Eisai tout Alzheimer's research at AD/PD 2022
2019 05 21 17 23 2291 Liquid Biopsy Labs Test Tubes 400
Leukemia
Sysmex develops new leukemia liquid biopsy test
2021 10 01 15 30 5893 2021 10 01 Xn 1000 Slanted Right 400
Plasmodium
Sysmex introduces automated analyzer for malaria detection
At-home or Lab-based STI testing/collection
Sponsor Content
At-home or Lab-based STI testing/collection
More in Collaboration
Exact Sciences, Watchmaker Genomics partner to improve DNA methylation technology
Exact Sciences has partnered with Watchmaker Genomics to develop and commercialize technology for analyzing DNA methylation.
September 6, 2023
Dna Genome Gene Targeted Social
Twist Bioscience, Ono Pharmaceutical to collaborate on autoimmune disease drug development
Synthetic biology and genomics company Twist Bioscience has entered into a collaboration with Ono Pharmaceutical, one of the largest pharmaceutical companies in Japan, to discover and develop drugs for autoimmune diseases.
September 5, 2023
Test Tube Liquid Sample Social
Ginkgo Bioworks, Google Cloud to collaborate on AI tools
Ginkgo Bioworks and Google Cloud have entered into a strategic five-year strategic partnership to develop artificial intelligence (AI) tools for biology and biosecurity.
September 6, 2023
Artificial Intelligence Ai Hand Social
Oxford Nanopore, IQVIA form nanopore sequencing partnership
Oxford Nanopore Technologies and IQVIA have struck a partnership to broaden access to nanopore sequencing technology, saying it will boost genomics research and patient care.
August 31, 2023
Business Handshake Intelligence Social
CrisprBits, MolBio Diagnostics to collaborate on POC tests
The collaboration will leverage CrisprBits’ expertise in biotechnology and MolBio’s translation, manufacturing, and distribution abilities to build POC tests that detect pathogens and genetic markers.
August 23, 2023
Crispr Tiles Social
Visiopharm, Boston Cell Standards team up to support higher assay requirements
If the higher standards are enforced, the collaboration could help enable a revised approach to the regulation of IHC that is intended to increase standardization through the use of modern clinical laboratory quality assurance protocols.
August 17, 2023
Test Tubes Social
Amoy Diagnostics, AstraZeneca partner on CDx for lung cancer therapy
This agreement is the latest in ongoing collaborations to develop and commercialize AmoyDx assays for companion diagnostic use with AstraZeneca's prostate, breast, and ovarian cancer therapies.
August 16, 2023
Cancer Lung 3 D Black Social
Quest Diagnostics teams up with Envision Science on prostate cancer biomarkers
The test aims to improve the accuracy of grading biopsies for prostate cancer, which is one of the most prevalent and deadly cancers affecting men.
July 27, 2023
Prostate Cancer 3 D Rendering Social
Illumina inks deal to sell Pillar Biosciences’ cancer assays
Pillar, which has partnerships with Beckman Coulter Life Sciences and Labcorp, designed its NSCLC and CRC panel to run on the Illumina MiSeq Dx instrument. The instrument is a next-generation sequencing (NGS) platform for in vitro diagnostic testing.
July 26, 2023
Cancer Cell Target2 Social
AccuStem Sciences and EmeritusDX team up on breast cancer assay, product portfolio
Initially, the partnership will focus on furthering the validation of StemPrintER, AccuStem’s recurrence predictor assay for patients with breast cancer.
July 19, 2023
Business Man Handshake Social
MGI Tech, Xpress Genomics partner on sequencing technologies
The agreement is aimed at developing scalable solutions that combine Xpress Genomics’ deep single-cell RNA sequencing expertise with MGI's automation and sequencing technologies.
June 14, 2023
Sequencing Dna Rna Pcr Social
MGI Tech, AddLife announce Nordic regional distribution agreement
Under the agreement, AddLife will distribute MGI Tech’s products through its four Triolab Group subsidiaries: Triolab Sweden, Triolab Norway, Triolab Denmark (Iceland), and Triolab Finland. The subsidiaries will act as separate distributors.
June 12, 2023
Business Man Handshake Social
Page 1 of 37
Next Page